Yong He

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 8

Top Topics

Tyrosine Kinase

Rheumatoid Arthritis Patients

Small Cell Lung Cancer

Top Venues

Cancer medicine

The clinical respiratory journal

This page only lists publications with an associated author ORCID identifier.

Publications

Chenglong Zhao, Jianghua Li, Yong-Chang Zhang, Rui Han, Yubo Wang, Li Li, Yimin Zhang, Mengxiao Zhu, Jie Zheng, Haiwei Du, Chen Hu, Cheng-Zhi Zhou, Nong Yang, Shangli Cai, Yong He
The rational application of liquid biopsy based on next-generation sequencing in advanced non-small cell lung cancer. Cancer medicine (2022)
Hengyi Chen, Conghua Lu, Caiyu Lin, Li Li, Yubo Wang, Rui Han, Chen Hu, Yong He
VPS34 suppression reverses osimertinib resistance via simultaneously inhibiting glycolysis and autophagy. Carcinogenesis 42 (6) (2021)
Hengyi Chen, Caiyu Lin, Tao Peng, Cheng Hu, Conghua Lu, Li Li, Yubo Wang, Rui Han, Mingxia Feng, FenFen Sun, Yong He
Metformin reduces HGF-induced resistance to alectinib via the inhibition of Gab1. Cell death & disease 11 (2) (2020)
Rui Han, Shuai Hao, Conghua Lu, Chong Zhang, Caiyu Lin, Li Li, Yubo Wang, Chen Hu, Yong He
Aspirin sensitizes osimertinib-resistant NSCLC cells in vitro and in vivo via Bim-dependent apoptosis induction. Molecular oncology 14 (6) (2020)
Vassiliki A Papadimitrakopoulou, Ji-Youn Han, Myung-Ju Ahn, Suresh R Ramalingam, Angelo Delmonte, Te-Chun Hsia, Janessa Laskin, Sang-We Kim, Yong He, Chun-Ming Tsai, Toyoaki Hida, Makoto Maemondo, Terufumi Kato, Suzanne Jenkins, Sabina Patel, Xiangning Huang, Gianluca Laus, Aleksandra Markovets, Kenneth S Thress, Yi-Long Wu, Tony Mok
Epidermal growth factor receptor mutation analysis in tissue and plasma from the AURA3 trial: Osimertinib versus platinum-pemetrexed for T790M mutation-positive advanced non-small cell lung cancer. Cancer 126 (2) (2019)
Li Li, Yubo Wang, Weiwei Shi, Mengxiao Zhu, Zhulin Liu, Nuo Luo, Yanwu Zeng, Yong He
Serial ultra-deep sequencing of circulating tumor DNA reveals the clonal evolution in non-small cell lung cancer patients treated with anti-PD1 immunotherapy. Cancer medicine 8 (18) (2019)
Yong-Hong Pan, Cai-Yu Lin, Cong-Hua Lu, Li Li, Yu-Bo Wang, Heng-Yi Chen, Yong He
Metformin synergistically enhances the antitumor activity of the third-generation EGFR-TKI CO-1686 in lung cancer cells through suppressing NF-κB signaling. The clinical respiratory journal 12 (12) (2018)
Hengyi Chen, Rongbing Jin, Yubo Wang, Li Li, Kunlin Li, Yong He
The Utility of 18F-FDG PET/CT for Monitoring Response and Predicting Prognosis after Glucocorticoids Therapy for Sarcoidosis. BioMed research international 2018 (2018)